[ad_1]
The EU approved Johnson & Johnson’s coronavirus vaccine. Photo: flickr
The European Medicines Agency (EMA) has approved the Janssen coronavirus vaccine manufactured by the American company Johnson & Johnson for use in the European Union for people over 18 years of age.
This was reported by the EMA press service.
An agency committee, after careful evaluation, concluded that the vaccine data is reliable and meets criteria for efficacy, safety, and quality. This makes Janssen the fourth vaccine approved by the European Union. The main difference between the Johnson & Johnson drug and other vaccines is that the Janssen vaccine needs to be given only once, only one dose is required.
“Results from human clinical trials in the United States, South Africa, and Latin America have shown that Janssen’s COVID-19 vaccine is effective in preventing COVID-19 in people over the age of 18. More than 44,000 people participated in this study. Half of them received a single dose of the vaccine and half received a placebo (sham injection). People did not know whether they were injected with the Janssen COVID-19 vaccine or a placebo, “the EMA said.
According to the study, the effectiveness of the vaccine is 67%. However, the side effects were mostly mild to moderate and disappeared within days after vaccination. The most common side effects listed were headaches, muscle aches, nausea, and fatigue.
“The safety and efficacy of the vaccine will continue to be monitored as it is used throughout the EU, through the EU pharmacovigilance system and further research conducted by the company and European authorities,” the regulator said in a statement. .
Remember that Johnson & Johnson’s Janssen vaccine has already been approved for use in Canada.
Bahrain was also reported to be the first state in the world to approve Johnson & Johnson’s coronavirus drug.
Subscribe to the Politics of the Country telegram channel to receive clear, understandable and fast analysis on political events in Ukraine.
